PAVmed (PAVM) Long-Term Debt Repayments (2019 - 2021)
PAVmed's quarterly Long-Term Debt Repayments came in at $14.8 million in Q1 2021, up 7776.6% quarter-over-quarter from -$193002.0 in Q4 2019.
PAVmed has reported Long-Term Debt Repayments for 2 years, with the latest figure at $14.8 million in Q1 2021.
- For the quarter ending Q1 2021, Long-Term Debt Repayments changed N/A year-over-year to $14.8 million; the trailing twelve-month figure through Dec 2021 stood at $14.8 million (changed N/A YoY), and the FY2022 full-year result was $6.0 million, down 59.48% from the prior year.
- Long-Term Debt Repayments for Q1 2021 stood at $14.8 million, up from -$193002.0 in the prior quarter.
- The five-year high for Long-Term Debt Repayments was $14.8 million in Q1 2021, with the low at -$193002.0 in Q4 2019.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Long-Term Debt Repayments (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | 1.42 Bn |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 1.00 Bn |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | - |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | - |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | - |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | - |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | - |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | - |
| 10 | PAVmed | 4.15 Mn | -9.02 Mn | -703,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2021 | 14.82 Mn |
| Mar 31, 2021 | 14.82 Mn |
| Dec 31, 2019 | -193,002.00 |
| Dec 31, 2019 | -193,002.00 |
| Jun 30, 2019 | 119,811.00 |
| Jun 30, 2019 | 119,811.00 |
| Mar 31, 2019 | 159,191.00 |
| Mar 31, 2019 | 159,191.00 |